Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Observational Program of Betaserc® (Betahistine Dihydrochloride) to Evaluate Effectiveness in Patients With Vestibular Vertigo in Routine Practice

NCT01759251 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01759251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01759251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Observational Program of Betaserc® (Betahistine Dihydrochloride) to Evaluate Effectiveness in Patients With Vestibular Vertigo in Routine Practice
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2014
Enrollment
309 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

vertigo